COCH Company Profile and Key Details

Short-term trend indicators are bullishly aligned (SMA20 11.82%, SMA50 5.09%, SMA200 -34.57%). The stock’s 14-day RSI is 53.43 (neutral), while the ATR of 0.09 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -63.32% below its high and over 93.24% above its low. Average 10-day trading volume of 182.74 thousand shares is below the 3-month average of 330.57 thousand, indicating normal recent market interest.

Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 1 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $2.50 to $2.50. The high target offers 262.32% upside. The low target suggests 262.32% downside. The mean target is $2.50. This offers 262.32% upside. Envoy Medical, Inc. earnings surprise history is a mixed track record. The quarter that ended May 11, 2026, missed forecasts by -42.86%. The prior quarter beat by 8.33%. Over the last six quarters, Apple has recorded several small beats. These include 36.36% in March 28, 2025.

Envoy Medical, Inc. has 21.52 million shares outstanding. The public float is 10.85 million shares, elevated short interest at 2.76% of float. This equals 301.39 thousand shares. The short ratio is 0.48 days. Institutional investors hold 117.24% of the float. Insiders own 49.46%. TAYLOR GLEN A holds 11.25 million shares, Anzu SPAC GP I LLC has 1.00 million shares and BRYNELSEN CHARLES has 600.00 thousand shares. Over the past six months, insider transactions show net buying. They sold 0.00 shares across 0 transactions.

Envoy Medical, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $0.06. This means the shares are trading above this model’s fair value.

Envoy Medical, Inc. (NASDAQ:COCH) closed at $0.69 USD, gaining $0.01 (1.52%) from the previous close of $0.68. The stock is currently mid-range between its 52-week high and low $0.36 and $1.89. With a market capitalization of about $14.43 million, Envoy Medical, Inc. is classified as a micro-cap and shows higher-than-market volatility (beta ~1.86). Key stats such as the average daily volume over the past year has been around 328.80 thousand shares, volume is running light vs its 52-week average. Headquartered in White Bear Lake, MN, Envoy Medical, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO Brent T. Lucas, the company employs approximately 43 people and listed since April 29, 2021. Envoy Medical, Inc. is a healthcare company dedicated to developing innovative medical technologies that address the full spectrum of hearing loss.

Envoy Medical, Inc. trades at a P/E ratio of -0.68, slightly below the S&P 500 average, with a price-to-sales ratio of 61.95 and a price-to-book ratio of 4.55 trading at moderately above to book value. The P/FCF stands at -0.7, also above market averages.

Envoy Medical, Inc. (NASDAQ:COCH) shares are flat -0.3% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Envoy Medical, Inc. trading at a premium to the broader market with a P/E of -0.68. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $7.55, suggesting 988.37% upside. Our AI forecast model points to short-term strength (8.12% over two weeks), a medium-term fall (-49.55% over three months), and a longer-term gain (91.73% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Envoy Medical, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 8.12%, with price expected at $0.75 by July 27, 2026, within a range of $0.71 to $0.79 3-Month Outlook: Projected fall of -49.55%, reaching $0.35 by October 08, 2026, with a range of $0.31 to $0.38. 1-Year Outlook: Projected gain of 91.73%, with price at $1.33 by July 13, 2027, within a range of $0.00 to $0.00.